MdmX is a substrate for the deubiquitinating enzyme USP2a.
N Allende-Vega1, A Sparks, D P Lane
1CR-UK Cell Transformation Research Group, Division of Molecular Medicine, Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK.
Oncogene
|October 20, 2009
Summary
Ubiquitin-specific protease 2a (USP2a) deubiquitinates and stabilizes MdmX. USP2a knockdown destabilizes MdmX, and its suppression enhances cisplatin sensitivity in cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Ubiquitin Biology
Background:
- The Mdm2/p53 pathway is crucial for tumor suppression.
- Ubiquitin-specific protease 2a (USP2a) regulates Mdm2 and p53.
- MdmX is a key regulator in the p53 pathway.
Purpose of the Study:
- To investigate the role of USP2a in MdmX regulation.
- To determine if USP2a deubiquitinates MdmX.
- To explore the therapeutic potential of targeting USP2a in cancer treatment.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Western blotting to assess protein levels and ubiquitination.
- siRNA-mediated knockdown of USP2a in cancer cell lines.
- Cell viability assays to evaluate drug sensitivity.
Main Results:
- USP2a directly binds to and deubiquitinates MdmX, independent of Mdm2.
- USP2a overexpression prevents Mdm2-mediated MdmX degradation.
- Knockdown of USP2a destabilizes MdmX and reduces its protein levels.
- Cisplatin treatment downregulates USP2a and MdmX.
- USP2a suppression enhances cisplatin sensitivity in NTERA-2 cells.
Conclusions:
- USP2a is a novel regulator of MdmX stability.
- USP2a deubiquitination of MdmX is critical for its stability.
- USP2a downregulation by cisplatin contributes to MdmX reduction.
- Combined suppression of USP2a and cisplatin treatment shows therapeutic promise for cancer.
More Related Videos
09:45Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...